在肝细胞癌中,伦瓦替尼布诱导的红血:一个独特的病例报告

Xiaoqing Li1, Suhua Ma1, Qing She1

  • 1Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.

Frontiers in oncology
|April 9, 2025
PubMed
概括

辅助的伦瓦替尼与TACE一起改善了肝细胞癌的生存率. 然而,这种向疗法可能会导致像红血虫等副作用,需要对患者进行仔细监测.

相关概念视频